Back to events

Foundation Medicine at the 8th Annual Liquid Biopsy for Precision Oncology Summit

Join us for two exciting networking and learning opportunities as part of our lead sponsorship at the meeting:

  1. Wednesday, February 28th, 9 am – 12 pm:
    Foundation Medicine will be hosting a workshop to discuss “What's Next In the Future of Liquid Biopsy,” featuring voices from the industry in partnership with Foundation Medicine.
  • Discussion on strategic trial design using ctDNA monitoring in drug development
  • Breakout groups to talk with your peers and Foundation Medicine experts about the opportunities and challenges with liquid biopsy testing in drug development today
  • Discussion on how to bring liquid biopsy to global markets through trials and commercialization, including our IVDR experience
  • This is an invitation only event, if interested please fill out the form below.


  1. Thursday, February 29th, 8:30 am – 9:00 am:
    Amanda Young, Senior Director, Lifecycle Product Development, will be presenting “Introducing an Improved ctDNA Tumor Fraction Method to Add Value in Translational Research, Clinical Trials & CDx Development”
  • Discussion on the value of ctDNA monitoring for research and clinical trial programs, including both early- and late-stage disease for MRD and treatment response
  • Confidence in negative results from a liquid biopsy test, now possible for wild-type biomarkers in trial enrollment
  • New data on the value of ctDNA tumor fraction in lung, breast, bladder, and kidney cancers
  • Learn more about our Discovery & Translational Research capabilities here

Hilton La Jolla Torrey Pines, San Diego 
10950 N Torrey Pines Rd, La Jolla, CA 92037

Schedule a meet & greet

Interested in Attending our Workshop or Scheduling a Meeting with Us